Global Celiac Disease Market, By Treatment (Infliximab, Larazotide Acetate, Gluten Free Diet, Others), Route of Administration (Oral, Parenteral), End Users (Hospitals, homecare, Others), Distribution Channel (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy)-Industry Trends and Forecast to 2029.
Market Analysis and Insights
Celiac disease is an autoimmune illness in which a protein called gluten damages the small intestine's membrane. Gluten can be present in grains such as rye, barley, and wheat. Gluten causes an immunological reaction that damages the villi in the small intestine (small finger-like projections in the small intestine which promote absorption). The body's ability to absorb proteins, nutrients, lipids, vitamins, carbs, and minerals is hampered by the damage. This eventually leads to malnutrition.
Data Bridge Market Research analyses that the celiac disease market was valued at USD 720 million in 2021 and is likely to reach USD 1,588.86 million by 2029 is estimated to grow at a CAGR of 10.40% during the forecast period of 2022 to 2029. The market report curated by the Data Bridge Market Research team includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Report Scope and Market Segmentation
|
Report Metric
|
Details
|
|
Forecast Period
|
2022 to 2029
|
|
Base Year
|
2021
|
|
Historic Years
|
2020 (Customizable to 2019 - 2014)
|
|
Quantitative Units
|
Revenue in USD Million, Volumes in Units, Pricing in USD
|
|
Segments Covered
|
Treatment (Infliximab, Larazotide Acetate, Gluten Free Diet, Others), Route of Administration (Oral, Parenteral), End Users (Hospitals, homecare, Others), Distribution Channel (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy)
|
|
Countries Covered
|
U.S., Canada, Mexico, Brazil, Argentina, Peru, Rest of South America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific, Saudi Arabia, U.A.E, Egypt, Israel, Kuwait, South Africa, Rest of Middle East and Africa
|
|
Market Players Covered
|
Innovate Biopharmaceuticals (US), Teva Pharmaceutical Industries Ltd (Israel), ImmunogenX, LLC (US), Amgen (US), ChemoCentryx, Inc (US), Anokion SA (Switzerland), COUR Pharmaceutical (US), F. Hoffmann-La Roche Ltd (Switzerland), BioLineRx Ltd (Israel), and Takeda Pharmaceutical Company Limited (Japan)
|
|
Market Opportunities
|
|
Market Definition
Celiac disease, also known as the celiac sprue or gluten-sensitive enteropathy. It is an immune reaction to eating gluten, a protein found in barley, wheat and rye. Eating gluten triggers an immune response in one’s small intestine.
Celiac Disease Market Dynamics
Drivers
Major factors that are expected to boost the growth of the celiac disease market in the forecast period are follows:
- Rise in the incidence of celiac disease population
Due to the growing celiac disease population, there is a rise in the demand in the application of gluten-free products which acts as one of the major factors driving the growth of celiac disease market.
- Increase in the investment in research and development
Robust research and development activities are bringing newer treatment options which is one of the major contributor to the market growth.
- Growing awareness regarding the celiac disease
Rising awareness related to the disease because consumption of gluten is further anticipated to propel to the market growth.
Opportunities
In addition, the growing initiatives by the government will further provide potential opportunities for the growth of the celiac disease market in the coming years.
Restraints/Challenges
On the other hand, the decrease in the number of effective treatment is further projected to impede the growth in the celiac disease market in the timeline period. However, the increased cost involved in research might further challenge the growth of the celiac disease market in the near future.
This celiac disease market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on celiac disease market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Patient Epidemiology Analysis
The celiac disease market also provides you with detailed market analysis for patient analysis, prognosis and cures. Prevalence, incidence, mortality, adherence rates are some of the data variables that are available in the report. Direct or indirect impact analyses of epidemiology to market growth are analysed to create a more robust and cohort multivariate statistical model for forecasting the market in the growth period.
COVID-19 Impact on Celiac Disease Market
The pandemic of COVID-19 has had a huge impact on the celiac disease market. Lockdowns and isolation during pandemics complicate the disease management and medication adherence. The lack of access to health-care facilities for routine treatment and medication administration will further affect the market. On the other hand, the development of vaccines and renunciation of lockdown has helped the market to advance its growth. Also the market players are investing to improve celiac disease market growth in the forecast period.
Global Celiac Disease Market
The celiac disease market is segmented on the basis of treatment, type, route of administration, end users and distribution channel. The growth amongst these segments will help you analyze meager growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Treatment
- Infliximab
- Larazotide Acetate
- Gluten Free Diet
- Others
On the basis of treatment, the celiac disease market is segmented into infliximab, larazotide acetate, gluten free diet, others.
Route of Administration
- Oral
- Parenteral
On the basis of route of administration, the celiac disease market is segmented into Oral, Parenteral.
End Users
- Hospitals
- homecare
- Others
On the basis of end users, the celiac disease market is segmented into hospitals, homecare, others.
Distribution Channel
- Hospital Pharmacy
- Online Pharmacy
- Retail Pharmacy
On the basis of distribution channel, the celiac disease market is segmented into hospital pharmacy, online pharmacy, retail pharmacy.
Celiac Disease Market Regional Analysis/Insights
The celiac disease market is analysed and market size insights and trends are provided by country, treatment, type, route of administration, end users and distribution channel as referenced above.
The countries covered in the celiac disease market report are the U.S., Canada, Mexico in North America, Brazil, Argentina, Peru, Rest of South America, as part of South America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific, Saudi Arabia, in the Asia-Pacific, U.A.E, Egypt, Israel, Kuwait, South Africa, Rest of Middle East and Africa, as a part of Middle East and Africa.
North America dominates the celiac disease market due to the rise in the refined healthcare expenses. Furthermore, the increase in the patient awareness level growing incidence of celiac diseases will further boost the growth of the celiac disease market in the region during the forecast period.
Europe is projected to observe significant amount of growth in the celiac disease market due to the occurrence of global market players. Moreover, the rising government support for vaccine development is further anticipated to propel the growth of the celiac disease market in the region in the coming years.
The country section of the report also provides individual market impacting factors and changes in regulations in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, disease epidemiology and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.
Competitive Landscape and Celiac Disease Market Share Analysis
The celiac disease market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to celiac disease market.
Some of the major players operating in the celiac disease market are:
- Innovate Biopharmaceuticals (US)
- Teva Pharmaceutical Industries Ltd (Israel)
- ImmunogenX, LLC (US)
- Amgen (US)
- ChemoCentryx, Inc (US)
- Anokion SA (Switzerland)
- COUR Pharmaceutical (US)
- F. Hoffmann-La Roche Ltd (Switzerland)
- BioLineRx Ltd (Israel)
- Takeda Pharmaceutical Company Limited (Japan)
SKU-